BioSpace News Archive

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced that it has appointed Mark A. Bach, M.D., Ph.D., as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases.

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today reviewed recent business accomplishments and reported financial results for the quarter ended September 30, 2020.

TheraCell Inc., a leading bone technology company today announced that it has completed the first three spine surgical cases using the world’s first ever demineralized bone fiber screw anchor.

Bristol Myers Squibb (NYSE:BMY) today announced positive results from POETYK PSO-1, the first pivotal Phase 3 trial evaluating deucravacitinib (BMS-986165), a novel, oral, selective tyrosine kinase 2 (TYK2) inhibitor, for the treatment of patients with moderate to severe plaque psoriasis.

Vifor Fresenius Medical Care Renal Pharma Ltd. and ChemoCentryx, Inc., announced that the European Medicines Agency accepted to review the Marketing Authorization Application for avacopan for the treatment of patients with ANCA-associated vasculitis and microscopic polyangiitis ), a group of rare and severe autoimmune diseases with high need for targeted therapies.

Adds photochemical machining, metal forming and sensor technology for minimally invasive surgical devices

The shareholders in Oncopeptides AB, reg. no. 556596-6438, with registered office in the municipality of Stockholm, are hereby given notice to attend the Extraordinary General Meeting on Friday 4 December 2020.

Vizient, Inc. announced that pharmacy expert Katrina Harper , PharmD, MBA, BCPS, clinical pharmacy director, will present at the Healthcare Distribution Alliance’s 2020 Traceability Online Seminar . The event, which is being held virtually Nov. 2-4, brings together stakeholders from the health care supply chain to learn more about upcoming DSCSA implementation milestones for serialization and traceability technologies t

InspireMD, Inc., the developer of the CGuard™ Embolic Prevention System for the prevention of stroke caused by carotid artery disease, announces the appointment of Andrea Tommasoli as senior vice president of global sales and marketing.

PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on developing its clinically-validated and patent-protected PLxGuard™ delivery system to provide more effective and safer products, VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”™), announced today that the Company will release its 2020 third quarter financial results on Friday, November 13, 2020